Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

BackgroundMineralocorticoid receptor antagonist (MRA) therapy may be beneficial to patients with atrial fibrillation (AF), but little is known about their use in patients with AF and subsequent outcomes. Methods and ResultsIn order to better understand MRA use and subsequent outcomes, we performed a...

Full description

Bibliographic Details
Main Authors: Marat Fudim, Peter R. Liu, Peter Shrader, Rosalia G. Blanco, Larry A. Allen, Gregg C. Fonarow, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Elaine Hylek, Alan S. Go, Laine Thomas, Eric D. Peterson, Jonathan P. Piccini
Format: Article
Language:English
Published: Wiley 2018-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
mineralocorticoid antagonist
stroke
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.007987

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.007987

Similar Items